These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38134949)

  • 21. Toxoplasmosis as an Early Complication of Allogeneic Hematopoietic Cell Transplantation.
    Robin C; Leclerc M; Angebault C; Redjoul R; Beckerich F; Cabanne L; Foulet F; Pautas C; Toma A; Maury S; Botterel F; Cordonnier C
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2510-2513. PubMed ID: 31381996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute exacerbation of pulmonary toxoplasmosis during corticosteroid therapy for immune thrombocytopenia: A case report and literature review.
    Omori K; Imoto N; Norose K; Maeda M; Hikosaka K; Kurahashi S
    Medicine (Baltimore); 2021 Dec; 100(51):e28430. PubMed ID: 34941194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebral toxoplasmosis developed after unrelated bone marrow transplantation for acute myeloid leukemia].
    Hirate T; Kitazawa H; Sakaguchi H; Akita N; Hasegawa C; Yamamoto K; Kutsuna S; Mikita K; Mori T; Hama A; Yoshida N
    Rinsho Ketsueki; 2023; 64(10):1275-1279. PubMed ID: 37914240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxoplasma qPCR kinetics to guide pre-emptive treatment of toxoplasmosis after allogeneic hematopoietic stem cell transplantation.
    Aerts R; Xhaard A; Robin C; Groll AH; Cordonnier C; Lagrou K; Bretagne S
    Clin Infect Dis; 2024 Oct; ():. PubMed ID: 39378321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation Recipients.
    Yetmar ZA; Thoendel MJ; Bosch W; Seville MT; Hogan WJ; Beam E
    Transplant Cell Ther; 2023 Mar; 29(3):206.e1-206.e7. PubMed ID: 36526261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience.
    Slavin MA; Meyers JD; Remington JS; Hackman RC
    Bone Marrow Transplant; 1994 May; 13(5):549-57. PubMed ID: 8054907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting.
    Paccoud O; Guitard J; Labopin M; Surgers L; Malard F; Battipaglia G; Duléry R; Hennequin C; Mohty M; Brissot E
    Bone Marrow Transplant; 2020 Jan; 55(1):93-99. PubMed ID: 31435031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group.
    Matsuo Y; Takeishi S; Miyamoto T; Nonami A; Kikushige Y; Kunisaki Y; Kamezaki K; Tu L; Hisaeda H; Takenaka K; Harada N; Kamimura T; Ohno Y; Eto T; Teshima T; Gondo H; Harada M; Nagafuji K
    Eur J Haematol; 2007 Oct; 79(4):317-21. PubMed ID: 17680814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low seroprevalence and low incidence of infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) in pediatric hematopoietic cell transplantation donors and recipients: Polish nationwide study.
    Czyzewski K; Fraczkiewicz J; Salamonowicz M; Pieczonka A; Zajac-Spychala O; Zaucha-Prazmo A; Gozdzik J; Styczynski J
    Folia Parasitol (Praha); 2019 Nov; 66():. PubMed ID: 31823860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxoplasmosis after allogeneic hematopoietic stem cell transplantation: Impact of serostatus-based management.
    Amikura T; Kikuchi T; Kato J; Koda Y; Sakurai M; Yamazaki R; Mikita K; Saburi M; Nakazato T; Mori T
    Transpl Infect Dis; 2021 Jun; 23(3):e13506. PubMed ID: 33174304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis.
    Gourishankar S; Doucette K; Fenton J; Purych D; Kowalewska-Grochowska K; Preiksaitis J
    Transplantation; 2008 Apr; 85(7):980-5. PubMed ID: 18408578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers.
    Adekunle RO; Sherman A; Spicer JO; Messina JA; Steinbrink JM; Sexton ME; Lyon GM; Mehta AK; Phadke VK; Woodworth MH
    Transpl Infect Dis; 2021 Aug; 23(4):e13636. PubMed ID: 33993599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis.
    Patrat-Delon S; Gangneux JP; Lavoué S; Lelong B; Guiguen C; le Tulzo Y; Robert-Gangneux F
    J Clin Microbiol; 2010 Jul; 48(7):2541-5. PubMed ID: 20463167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metagenomic Next-generation Sequencing May be a Tool for Timely Diagnosis of Seronegative and Primary Toxoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review.
    Lv Q; Cao Y; Wang J; Meng L; Wang G
    Pediatr Infect Dis J; 2024 Feb; 43(2):155-159. PubMed ID: 38190489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 10-year retrospective analysis of Toxoplasma gondii qPCR screening in allogeneic hematopoietic stem cell transplantation recipients.
    Xhaard A; Villate A; Hamane S; Michonneau D; Menotti J; Robin M; Sicre de Fontbrune F; Dhédin N; Peffault de la Tour R; Socié G; Bretagne S
    Bone Marrow Transplant; 2023 Feb; 58(2):152-159. PubMed ID: 36335254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to Trimethoprim-Sulfamethoxazole in a Pediatric Hematopoietic Stem Cell Transplant Recipient With Disseminated Toxoplasmosis: A Case Report.
    Khan A; Schwenk HT; Kohlman K; Bertaina A; Cho S; Montoya JG; Contopoulos-Ioannidis D
    J Pediatric Infect Dis Soc; 2021 Aug; 10(6):745-748. PubMed ID: 33693793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation.
    Edvinsson B; Lundquist J; Ljungman P; Ringdén O; Evengård B
    APMIS; 2008 May; 116(5):345-51. PubMed ID: 18452424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
    Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK
    Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral toxoplasmosis in an adolescent post allogeneic hematopoietic stem cell transplantation: successful outcome by antiprotozoal chemotherapy and CD4+ T-lymphocyte recovery.
    Kerl K; Ehlert K; Brentrup A; Schiborr M; Keyvani K; Becker K; Rossig C; Groll AH
    Transpl Infect Dis; 2015 Feb; 17(1):119-24. PubMed ID: 25581774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients.
    Hakko E; Ozkan HA; Karaman K; Gulbas Z
    Transpl Infect Dis; 2013 Dec; 15(6):575-80. PubMed ID: 24103000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.